Navigation Links
Mithridion raises $1.6M through angel networks

Madison, Wis. Mithridion, the University of Wisconsin-Madison spinoff developing a drug for people with Alzheimer's disease, has closed its first round of financing with $1.6 million, of which it has received the first portion, that will go toward buying lab equipment, hiring scientists and developing drug candidates.

Trevor Twose, Mithridion's ......

Full article >>> als are successful Mithridion will partner or sell to a large pharmaceutical company in stage two or three trials. By that time, its technology will be reasonably proven enough, at least, for a large pharma to take on the final testing and marketing.

Mithridion's product is based on research by Jeff Johnson,......

Full article >>>
'"/>

Source:wistechnology.com By Jason Stitt 02/01/06


Related biology technology :

1. Mithridion wins grants for Alzheimers research
2. Digital Healthcare Conference, Mithridion, lack of degrees
3. Madison-based Mithridion seeks to capitalize on Alzheimers breakthrough
4. TomoTherapy raises $223 million in IPO
5. Fusion 2007: CA chief says IT complexity raises risk
6. Inline intellectual property raises legal issues
7. Biotech with Madison ties raises $21M in capital
8. ConjuGon raises $3.3 million to fund clinical trials
9. Nerites raises $1 million to improve medical tech
10. Brady Corp. raises $137 million in public offering
11. aOva Technologies raises $3 million
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/9/2016)... ... February 09, 2016 , ... ... innovations on its free and validated Electronic Data Capture (EDC) system ClinCaptureand its ... in Clinical Trials West Coast 2016 Conference in San Mateo, California on February ...
(Date:2/9/2016)... HOUSTON , Feb. 9, 2016 /PRNewswire/ ... virus-driven immunotherapies for cancer, announced that its ... the European Commission as an orphan medicinal ... the deadliest form of glioma, strikes approximately ... and EU. http://photos.prnewswire.com/prnh/20160208/330986LOGO ...
(Date:2/9/2016)... 9, 2016 DelveInsight,s, ... report provides in depth insights on the ... the Protein-Tyrosine Phosphatase 1B (PTP1B) Inhibitors. The ... various stages of development including Discovery, Pre-clinical, ... and Preregistration. Report covers the product clinical ...
(Date:2/8/2016)... Inc. today announced that Director Robert A. Ingram has ... addition, Robert Keegan has been appointed to the Board ... --> North Carolina . --> ... $32.8 million of net proceeds in a private Mezzanine B financing ... Research Triangle area of North Carolina . ...
Breaking Biology Technology:
(Date:1/15/2016)... Rico , Jan. 15, 2016 Recent ... and small to find new ways to ensure data ... iOS and Android that ... on biometrics, transforming it into a hardware authorization token. ... users swipe their fingerprint on their KodeKey enabled device ...
(Date:1/11/2016)... Calif. , Jan. 11, 2016 Synaptics ... human interface solutions, today announced that its ClearPad ® ... integration (TDDI) products won two separate categories in the ... Mobile Innovator and Best Technology Breakthrough. The Synaptics ® ... cost, a simplified supply chain, thinner devices, brighter displays ...
(Date:1/8/2016)... 8, 2016 NXTD ), a ... ® , a privately held leading direct seller of ... 5000 fastest-growing company announced that on December 31, ... million in Nxt-ID to develop a proprietary new wireless ... ® , a unique smart wallet that serves to ...
Breaking Biology News(10 mins):